ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fatigue"

  • Abstract Number: 1157 • ACR Convergence 2023

    Experience of Pain in Adults with Idiopathic Inflammatory Myopathies, Myositis

    Helene Alexanderson1, Masoumeh Tasaroffi2, Henrik Pettersson3 and Malin Regardt3, 1Karolinska Institutet, Stockholm, Sweden, 2Danderyds Hospital, Stockholm, Sweden, 3Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Knowledge of pain in myositis is limited. Recent research suggest that pain is a common symptom in adults with myositis and deemed as one…
  • Abstract Number: 2019 • ACR Convergence 2023

    2023 EULAR Recommendations for the Management of Fatigue in People with Inflammatory Rheumatic and Musculoskeletal Diseases

    Emma Dures1, Bayram Farisogullari2, Eduardo Santos3, Anna Molto4, Caroline Feldthusen5, Claire Harris6, Corinna Elling-Audersch7, Deirdre Conolly8, Elena Elefante9, Fernando Estévez-López10, Ilaria Bini11, Jette Primdahl12, Kirsten Hoeper13, Marie Urban14, Mart van de Laar15, Marta Redondo16, Peter Böhm17, Raj Amarnani18, Rhys Hayward6, Rinie Geenen19, Simona Rednic20, Susanne Pettersson21, Tanja Thomsen22, Till Uhlig23, Valentin Ritschl24 and Pedro Machado25, 1Academic Rheumatology, Bristol Royal Infirmary; and Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, 2Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 3Health Sciences Research Unit: Nursing (UICISA: E), Nursing School of Coimbra (ESEnfC), Coimbra, Portugal, 4HOPITAL COCHIN AP-HP, Service de Rhumatologie, Paris, France, 5Institute of Neuroscience and Physiology, University of Gothenburg, Department of Health and Rehabilitation, Unit of Physiotherapy, Sahlgrenska Academy, Gothenburg, Sweden, 6Northwick Park Hospital, London North West University Healthcare NHS Trust, Department of Rheumatology, London, United Kingdom, 7Deutsche Rheuma-Liga Bundesverband e.V., Patient Research Partner, Bonn, Germany, 8School of Medicine, Trinity College Dublin, Discipline of Occupational Therapy, Dublin, Ireland, 9Rheumatology Unit, Department of clinical and experimental medicine, University of Pisa, Pisa, Italy, 10Harvard T.H. Chan School of Public Health, Department of Social and Behavioral Sciences, Boston, MA, 11Anmar, Young, Rome, Italy, Rome, Italy, 12University Hospital of Southern Denmark, Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark, 13Hannover Medical School, Department of Rheumatology and Immunology, Hannover, Germany, 14University Hospitals Bristol, Research Design Service, Bristol, United Kingdom, 15University of Twente, Department of Psychology, Health and Technology, Enschede, Netherlands, 16Camilo José Cela University, Faculty of Heath Sciences, Madrid, Spain, 17German League against rheumatism, Forschungspartner, Bonn, Germany, 18Barts Health NHS Trust, Barts Health Rheumatology Service, London, United Kingdom, 19Utrecht University, Vorstenbosch, Netherlands, 20Prof Dr Simona Rednic, Cluj, Romania, 21Karolinska Institute, Division of Rheumatology, Department of Medicine Solna, Stockholm, Sweden, 22University of Copenhagen, Copenhagen Centre for Arthritis Research, Centre for Rheumatology and Spine Diseases VRR, Rigshospitalet, Copenhagen, Denmark, 23Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway, 24Medical University of Vienna, Vienna, Austria, 25Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK. Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS trust, London, UK., London, United Kingdom

    Background/Purpose: Fatigue is prevalent in people with inflammatory rheumatic and musculoskeletal diseases (I-RMDs) and recognized as one of the most challenging symptoms to manage (1).…
  • Abstract Number: 1201 • ACR Convergence 2023

    Frailty and Its Impact on Patient Reported Outcomes in Polymyalgia Rheumatica

    Patricia Harkins1, Sharon Cowley2, David Kane3 and Richard Conway4, 1St James's Hospital, Dublin, Ireland, 2Tallaght University Hospital, Dublin, Dublin, Ireland, 3Tallaght University Hospital & Trinity College Dublin, Dublin, Ireland, 4Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Frailty is an increasingly important construct in the field of rheumatology, aiding the identification of individuals with increased vulnerability to accelerated clinical decline and…
  • Abstract Number: 2108 • ACR Convergence 2023

    Specific Symptom Clusters at Diagnosis Signal a Poorer Early RA Prognosis: Data from the Canadian Early Arthritis Cohort (CATCH)

    Susan Bartlett1, Clifton Bingham2, Orit Schieir3, Marie-France Valois4, Janet Pope5, Louis Bessette6, Gilles Boire7, Carol Hitchon8, Edward Keystone9, Carter Thorne10, Diane Tin11, Glen Hazlewood12 and Vivian Bykerk13, 1McGill University, Montreal, QC, Canada, 2Johns Hopkins Medicine, Baltimore, MD, 3McGill University, Montréal, QC, Canada, 4McGill University, Pointe-Claire, QC, Canada, 5University of Western Ontario, London, ON, Canada, 6Centre de l'Ostéoporose et de Rhumatologie de Québec, Quebec City, QC, Canada, 7Université de Sherbrooke, Sherbrooke, QC, Canada, 8University of Manitoba, Winnipeg, MB, Canada, 9Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 10Southlake Regional Health Centre, Newmarket, ON, Canada, 11Newmarket Rheumatology Consultants, Newmarket, ON, Canada, 12University of Calgary, Calgary, AB, Canada, 13Hospital for Special Surgery, New York, NY

    Background/Purpose: Symptom clusters are stable groups of 2+ symptoms that are related to each other and frequently co-occur. Identifying symptom clusters in early RA may…
  • Abstract Number: 1215 • ACR Convergence 2023

    Efficacy of Pharmacological Interventions: A Systematic Review Informing the 2023 EULAR Recommendations for the Management of Fatigue in People with Inflammatory Rheumatic and Musculoskeletal Diseases

    Bayram Farisogullari1, Eduardo Santos2, Emma Dures3, Rinie Geenen4 and Pedro Machado5, 1Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 2Health Sciences Research Unit: Nursing (UICISA: E), Nursing School of Coimbra (ESEnfC), Coimbra, Portugal, 3Academic Rheumatology, Bristol Royal Infirmary; and Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, 4Utrecht University, Vorstenbosch, Netherlands, 5Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK. Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS trust, London, UK., London, United Kingdom

    Background/Purpose: To identify the best evidence on the efficacy of pharmacological interventions in reducing fatigue in people with I-RMDs and to summarise their safety in…
  • Abstract Number: 2260 • ACR Convergence 2023

    Right Insular Cortex-Thalamic Functional Connectivity as a Potential Marker for Fatigue in Systemic Lupus Erythematosus and Primary Sjögren’s Syndrome

    Yuichiro fujieda1, Kodai Sakiyama1, Nobuya Abe1, Ryo Hisada1, Michihito Kono1, Masaru Kato1, Olga Amengual2, Khin Khin Tha3, Hisashi Shirakawa4 and Tatsuya Atsuma5, 1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 2Hokkaido University, Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan, 3Global Center for Biomedical Science and Engineering, Faculty of Medicine, Hokkaido University Hospital, Sapporo, Japan, 4Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto, Japan, 5Hokkaido University, Department of Rheumatology, Endocrinology and Nephrology, Sapporo, Japan

    Background/Purpose: Fatigue is a common symptom in patients with systemic lupus erythematosus (SLE) and primary Sjögren's syndrome (pSS). Resting-state functional magnetic resonance imaging (rs-fMRI) has…
  • Abstract Number: 1263 • ACR Convergence 2023

    Depression and Anxiety Risk Assessment in Patients with Rheumatic Diseases

    Luis Vega Sevilla1, Miguel Villarreal-Alarcon2, Diana Paola Flores-Gutierrez3, Maria Corral-Trujillo4, Ricardo Juarez4, Ivan Hernandez Galarza5, Jesus Alberto Cardenas-De la Garza6 and Dionicio A. Galarza-Delgado2, 1Hospital Universitario UANL, Garcia, Mexico, 2Hospital Universitario UANL, Monterrey, Mexico, 3Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico, 4Universidad Autónoma de Nuevo León, Monterrey, Mexico, 5University Hospital, UANL, San Pedro Garza Garcia, Mexico, 6Hospital Universitario "Dr. José Eleuterio González", San Nicolas, Mexico

    Background/Purpose: Depression is one of the most common psychiatric comorbidities in patients with rheumatic diseases. A study has shown that almost a third of patients…
  • Abstract Number: PP10 • ACR Convergence 2023

    Saved by Plants: How a Necessary Lifestyle Change Led to a Happier Life with Decreased Rheumatoid Arthritis Pain and Fatigue

    Shelley Fritz, Global Healthy Living Foundation, Nyack, NY

    Background/Purpose: After my RA diagnosis over eleven years ago, I was optimistic that the first biologic DMARD I took would slow the progression of my…
  • Abstract Number: 1285 • ACR Convergence 2023

    PROMIS Symptom Clusters Predict Disease Activity in the First 6 Months in Newly Diagnosed RA Patients Starting MTX Therapy: Data from the Canadian Early Arthritis Cohort

    Susan Bartlett1, Clifton Bingham2, Orit Schieir3, Marie-France Valois4, Gilles Boire5, Louis Bessette6, Janet Pope7, Diane Tin8, Carter Thorne9, Glen Hazlewood10, Carol Hitchon11, Edward Keystone12 and Vivian Bykerk13, 1McGill University, Montreal, QC, Canada, 2Johns Hopkins Medicine, Baltimore, MD, 3McGill University, Montréal, QC, Canada, 4McGill University, Pointe-Claire, QC, Canada, 5Université de Sherbrooke, Sherbrooke, QC, Canada, 6Centre de l'Ostéoporose et de Rhumatologie de Québec, Quebec City, QC, Canada, 7University of Western Ontario, London, ON, Canada, 8Newmarket Rheumatology Consultants, Newmarket, ON, Canada, 9Southlake Regional Health Centre, Newmarket, ON, Canada, 10University of Calgary, Calgary, AB, Canada, 11University of Manitoba, Winnipeg, MB, Canada, 12Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 13Hospital for Special Surgery, New York, NY

    Background/Purpose: We have previously shown that PROMIS-29 physical (pain, fatigue) and emotional (depression, anxiety) symptom clusters can be used to identify 4 distinct early RA…
  • Abstract Number: PP12 • ACR Convergence 2023

    Sjögren’s-Fatigue: Non-Therapeutic Lifestyle Adjustments to Help Manage My Most Problematic Symptom

    Susan Barajas, Sjögren's Foundation, Los Angeles, CA

    Background/Purpose: I was diagnosed with Sjögren's disease in 2015. I sought help from a rheumatologist after experiencing hand pain. I also had dry eyes and…
  • Abstract Number: 1375 • ACR Convergence 2023

    The Relative Burden of Fatigue Is Associated with High TSH/fT4 Ratio in Korean Patients with Primary Sjogren’s Syndrome

    Jee-in Lee1, Se Rim Choi2, You-Jung Ha2, Eun Ha Kang3, Keun-Suh Kim4, Joon Young Hyon5 and Yun Jong Lee6, 1Seoul National University of Bundang Hospital, Seongnam, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnamsi, South Korea, 3Seoul National University Bundang Hospital, Seongnam, South Korea, 4Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital, Seongnamsi, South Korea, 5Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnamsi, South Korea, 6Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea

    Background/Purpose: To investigate the prevalence of anti-thyroid autoantibodies, abnormal thyroid function, and their clinical impacts in Korean patients with primary Sjögren's syndrome (pSS). Methods: One…
  • Abstract Number: PP16 • ACR Convergence 2023

    Peer Health Coaches Help Scleroderma Patients Cope with Isolation

    Mary Alore1, Yen Chen2 and Susan Murphy3, 1Troy, MI, 2University of Michigan, Ann Arbor, MI, 3University of Michigan, Plymouth, MI

    Background/Purpose: In 2011, I felt extremely isolated with my new diagnosis of diffuse systemic sclerosis and sought support online and in support groups. In addition…
  • Abstract Number: 1381 • ACR Convergence 2023

    Fatigue and Associated Factors in Patients with Primary Sjogren’s Syndrome Compared to Secondary Sjogren’s Syndrome

    Hyeji Jeon, Hyun-Sook Kim and Kyung-Ann Lee, Soonchunhyang University Seoul Hospital, Seoul, South Korea

    Background/Purpose: Fatigue is one of the dominant symptoms of patients with Primary Sjogren's syndrome (pSS). However, whether fatigue is specific to pSS compared to secondary…
  • Abstract Number: 1424 • ACR Convergence 2023

    Early Fatigue Improvement with Guselkumab Associates with Longer Term Disease Control in Patients with Active Psoriatic Arthritis Reporting Substantial Fatigue: Post Hoc Analyses of a Sub-Population of a Phase 3, Randomized, Controlled Trial of Guselkumab in Biologic-Naïve Patients

    Dafna Gladman1, Xenofon Baraliakos2, Michael Starr3, Roberto Ranza4, Emmanouil Rampakakis5, Natalie shiff6, Francois Nantel7, Chenglong Han8, Andrew James Knowles Ostor9 and Philip J. Mease10, 1Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Department of Medicine, University of Toronto, Toronto, ON, Canada, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 3Division of Rheumatology, McGill University Health Center, Montreal, QC, Canada, 4Rheumatology Unit, Hospital das Clínicas da Universidade Federal de Uberlândia, Uberlândia, Brazil, 5McGill University, Department of Pediatrics / JSS Medical Research, Scientific Affairs, Montreal, QC, Canada, 6Immunology, Janssen Scientific Affairs, LLC / Adjunct, Community Health and Epidemiology, University of Saskatchewan, Horsham, PA, 7Nantel Medsci Consult, Consultant, Montreal, QC, Canada, 8Immunology, Janssen Global Services, LLC, Malvern, PA, 9Cabrini Hospital, Monash University & Emeritus Research / Australian National University, Canberra, Australia, 10Swedish Medical Center/Providence St. Joseph Health and University of Washington School of Medicine, Seattle, WA

    Background/Purpose: Fatigue is commonly reported by PsA patients (pts) and contributes to disease burden. The fully human IL-23p19-subunit inhibitor guselkumab (GUS) induces clinically meaningful and…
  • Abstract Number: 1575 • ACR Convergence 2023

    Takayasu Arteritis Is Associated with Worse Fatigue Than Healthy Controls Which Persists over Time – A Longitudinal Cohort Study

    Darpan Radheshyam Thakare, Upendra Rathore, Kritika Singh, Vikas Agarwal and Durga P Misra, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India

    Background/Purpose: Few studies have assessed patient-reported outcome measures in Takayasu arteritis (TAK), a rare large vessel vasculitis. We prospectively analysed fatigue and fibromyalgia in TAK…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology